CLEVELAND, Feb. 26, 2008 (PRIME NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) today announced it will host a conference call on Wednesday, February 27, 2008 at 4:15 PM (Eastern Time) to review the top-line data results of the Phase I clinical trial of ATHX-105, its leading drug development candidate for the treatment of obesity.
